SCHEMBL7438531

SCHEMBL7438531

CC(=O)c1ccc2c(c1)C(C)(CS)C(=O)N2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.50
IDO1 P14902 2/20 0.40
IP6K1 Q92551 1/20 0.39
NQO2 P16083 1/20 0.39
PDK2 Q15119 1/20 0.38
GAA P10253 2/20 0.37
CBX7 O95931 1/20 0.37
CDYL2 Q8N8U2 1/20 0.37
CDYL Q9Y232 1/20 0.37
CDY1; CDY1B Q9Y6F8 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
MAPT P10636 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
TLK2 Q86UE8 1/20 0.36
SLC2A1 P11166 1/20 0.36
MEN1 O00255 1/20 0.36
CYBB P04839 1/20 0.36
APP P05067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7427902 0.76 PGR (0.50) PGRIDO1IP6K1NQO2PDK2
SCHEMBL7438527 0.75 PGR (0.52) PGRIDO1IP6K1NQO2PDK2
SCHEMBL20268320 0.73 IP6K1 (0.55) PGRIP6K1PDE3BPDE3A
SCHEMBL20268826 0.73 IP6K1 (0.55) PGRIP6K1PDE3BPDE3A
SCHEMBL1764545 0.71 HDAC3 (0.54) PGRIP6K1GAAMAPTNPC1
SCHEMBL1874397 0.68 PGR (0.55) PGRIP6K1PDK2PDE3BPDE3A
SCHEMBL31117105 0.68 PGR (0.51) PGRPDK2CBX7CDYL2CDYL
SCHEMBL9462366 0.68 KDM4E (0.55) PGRPDE3BPDE3ANPC1
SCHEMBL7379550 0.68 PGR (0.51) PGRPDK2CBX7CDYL2CDYL
SCHEMBL27076405 0.68 MAPT (0.45) PGRGAAMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4933336-A Thiadiazinone, oxadiazinone and triazinone derivatives, and their use for treating acute or chronic heart disease LABORATOIRES SOBIO S.A. (FR) 1990-06-12 US disclosed
EP-0303418-A2 Substituted indolones, useful in the treatment of heart or asthmatic diseases SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) 1989-02-15 EP disclosed